Wednesday, February 10, 2010, 4:07am EST - Canadian Markets open in 5 hours and 23 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Alexza Pharmaceuticals Inc. (ALXA)

On Feb 9: 2.6705 USD   0.00 (0.00%)  
MORE ON ALXA
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
PERIOD ENDING 30-Sep-09 30-Jun-09 31-Mar-09 31-Dec-08
Total Revenue -   -   9,514   417  
Cost of Revenue -   -   -   -  
Gross Profit -   -   9,514   417  
Operating Expenses
Research Development 9,183   12,005   10,965   14,400  
Selling General and Administrative 3,824   4,205   3,864   4,015  
Non Recurring -   625   1,528   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (13,007) (16,835) (6,843) (17,998)
Income from Continuing Operations
Total Other Income/Expenses Net 677   (9) 97   293  
Earnings Before Interest And Taxes (12,330) (16,844) (6,746) 886  
Interest Expense 95   125   158   199  
Income Before Tax (12,425) (16,969) (6,904) 687  
Income Tax Expense -   -   -   15,714  
Minority Interest (59,998) 12,419   -   18,591  
Net Income From Continuing Ops (72,423) (4,550) (6,904) (15,027)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (72,423) (4,550) (6,904) (15,027)
Preferred Stock And Other Adjustments -   (5,190) 5,190   -  
Net Income Applicable To Common Shares ($72,423) ($9,740) ($1,714) ($15,027)

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Income Statement for Another Symbol:
Symbol Lookup
Latest News Canadian Indices


Reuters offers more in-depth Company Research , Stock Screening , and Risk Alerts on over 10,000 U.S. Equities.